ATE64528T1 - Tablette zur pharmazeutischen anwendung sukzessiver freisetzung. - Google Patents

Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.

Info

Publication number
ATE64528T1
ATE64528T1 AT87119166T AT87119166T ATE64528T1 AT E64528 T1 ATE64528 T1 AT E64528T1 AT 87119166 T AT87119166 T AT 87119166T AT 87119166 T AT87119166 T AT 87119166T AT E64528 T1 ATE64528 T1 AT E64528T1
Authority
AT
Austria
Prior art keywords
casing
layer
pharmaceutical use
active substance
barrier layer
Prior art date
Application number
AT87119166T
Other languages
English (en)
Inventor
Manna Aldo La
Paolo Colombo
Ubaldo Conte
Original Assignee
Pharmaidea Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaidea Srl filed Critical Pharmaidea Srl
Application granted granted Critical
Publication of ATE64528T1 publication Critical patent/ATE64528T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87119166T 1987-01-13 1987-12-23 Tablette zur pharmazeutischen anwendung sukzessiver freisetzung. ATE64528T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19064/87A IT1201136B (it) 1987-01-13 1987-01-13 Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
EP19870119166 EP0274734B1 (de) 1987-01-13 1987-12-23 Tablette zur pharmazeutischen Anwendung sukzessiver Freisetzung

Publications (1)

Publication Number Publication Date
ATE64528T1 true ATE64528T1 (de) 1991-07-15

Family

ID=11154233

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87119166T ATE64528T1 (de) 1987-01-13 1987-12-23 Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.

Country Status (10)

Country Link
US (1) US4865849A (de)
EP (1) EP0274734B1 (de)
JP (1) JPS63190822A (de)
KR (1) KR880008805A (de)
AT (1) ATE64528T1 (de)
AU (1) AU610112B2 (de)
DE (1) DE3770937D1 (de)
ES (1) ES2031491T3 (de)
IT (1) IT1201136B (de)
NZ (1) NZ223160A (de)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8915716D0 (en) * 1989-07-08 1989-08-31 Coopers Animal Health Pharmaceutical compositions
US5190760A (en) * 1989-07-08 1993-03-02 Coopers Animal Health Limited Solid pharmaceutical composition
SE464275B (sv) * 1989-07-31 1991-04-08 Aagerup Bengt Ny anvaendning av beta-receptorblockerare foer beredning av ett preparat verksamt mot menieres sjukdom
IT1237904B (it) * 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
IE66933B1 (en) * 1990-01-15 1996-02-07 Elan Corp Plc Controlled absorption naproxen formulation for once-daily administration
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5213807A (en) * 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
US5133892A (en) * 1990-10-17 1992-07-28 Lever Brothers Company, Division Of Conopco, Inc. Machine dishwashing detergent tablets
US5387421A (en) * 1991-01-31 1995-02-07 Tsrl, Inc. Multi stage drug delivery system
US5976571A (en) * 1991-01-31 1999-11-02 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
US5674530A (en) * 1991-01-31 1997-10-07 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
ES2074769T3 (es) * 1991-07-01 1995-09-16 Gergely Gerhard Procedimiento para la elaboracion de un preparado farmaceutico con, al menos, dos principios activos diferentes y uso de un preparado de este tipo.
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5609884A (en) * 1992-08-31 1997-03-11 G. D. Searle & Co. Controlled release naproxen sodium plus naproxen combination tablet
JPH09500097A (ja) * 1993-04-20 1997-01-07 ティエスアールエル インコーポレイテッド 多段階薬剤供給装置
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US6183778B1 (en) 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
GB9401894D0 (en) 1994-02-01 1994-03-30 Rhone Poulenc Rorer Ltd New compositions of matter
AU746091B2 (en) * 1995-04-03 2002-04-18 Chugai Seiyaku Kabushiki Kaisha Sucralfate containing pharmaceutical composition
US5985843A (en) * 1995-04-03 1999-11-16 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition containing sucralfate
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
NZ511442A (en) 1998-11-02 2003-02-28 Elan Corp Plc Multiparticulate modified release composition for multiple dosing of ADD patients with methylphenidate HCl
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
KR20020059653A (ko) 1999-10-29 2002-07-13 그린 마틴, 브라이언 쥐 테슬리 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
EP1337244A4 (de) 2000-10-30 2006-01-11 Euro Celtique Sa Hydrocodon-formulierungen mit kontrollierter freisetzung
US20040137062A1 (en) * 2001-05-25 2004-07-15 Sham Chopra Chronotherapy tablet and methods related thereto
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
CA2461870A1 (en) 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
ITMI20020514A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
US7157100B2 (en) * 2002-06-04 2007-01-02 J.B. Chemicals & Pharmaceuticals Ltd. Pharmaceutical composition for controlled drug delivery system
DE10297745T5 (de) * 2002-06-04 2006-03-02 J.B. Chemicals & Pharmaceuticals Ltd. Pharmazeutische Zusammensetzung für ein System zur kontrollierten Arzneistoffabgabe
DE10248652A1 (de) * 2002-10-18 2004-04-29 Solvay Interox Gmbh Verfahren zur Herstellung von staubfreien Erdalkaliperoxiden
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
EP2036546B1 (de) 2004-08-23 2018-10-10 PEJO Iserlohn Heilmittel-und Diät-GmbH & Co.KG Psychostimulantium mit einer pharmazeutischen Zusammensetzung
KR20070086340A (ko) * 2004-11-19 2007-08-27 스미스클라인 비참 코포레이션 약제학적 제품
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
US20090069275A1 (en) * 2006-02-17 2009-03-12 Rocca Jose G Low flush niacin formulation
SG174026A1 (en) 2006-08-03 2011-09-29 Nitec Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid disease
US8128460B2 (en) * 2006-09-14 2012-03-06 The Material Works, Ltd. Method of producing rust inhibitive sheet metal through scale removal with a slurry blasting descaling cell
EP2101713A1 (de) * 2006-12-05 2009-09-23 Universita' Degli Studi Di Parma Neue module, neue anordnungssets und neue anordnungen für die kontrollierte freisetzung von substanzen
WO2009023672A2 (en) * 2007-08-13 2009-02-19 Abuse Deterrent Pharmaceutical Llc Abuse resistant drugs, method of use and method of making
KR20150084013A (ko) 2007-10-12 2015-07-21 다케다 파마슈티칼스 유에스에이, 인코포레이티드 음식 섭취와 관계없이 위장 장애를 치료하는 방법
US20100233259A1 (en) * 2008-12-12 2010-09-16 Pascal Grenier Dosage form of ropinirole
EP2391369A1 (de) * 2009-01-26 2011-12-07 Nitec Pharma AG Glukokortikoid-behandlung von asthma mit verzögerter freisetzung
WO2010103367A1 (en) 2009-03-09 2010-09-16 Council Of Scientific & Industrial Research Pulsatile release composition of therapeutic agent
US9259394B2 (en) 2009-12-07 2016-02-16 Johnson & Johnson Consumer Inc. Partial dip coating of dosage forms for modified release
NZ627593A (en) 2012-02-22 2015-12-24 Duchesnay Inc Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof
GB201303781D0 (en) 2013-03-04 2013-04-17 Gauthier Pierre Pascal Oral timer device and method of using same
US11571390B2 (en) 2013-03-15 2023-02-07 Othemo Life Sciences, Inc. Abuse deterrent compositions and methods of use
NZ716017A (en) 2013-07-22 2020-07-31 Duchesnay Inc Composition for the management of nausea and vomiting
WO2015016256A1 (ja) * 2013-07-30 2015-02-05 ライオン株式会社 錠剤
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
JP6559912B2 (ja) * 2016-05-05 2019-08-14 トリアステック インコーポレイテッド 放出制御剤形
KR20230116831A (ko) * 2020-11-30 2023-08-04 에스에스 세야쿠 가부시키 가이샤 이부프로펜을 함유하는 고형 제제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109293C (de) * 1955-12-22
FR2100858B1 (de) * 1970-07-03 1975-06-06 Daiichi Seiyaku Co
JPS5333885Y2 (de) * 1974-08-01 1978-08-21
US4139589A (en) * 1975-02-26 1979-02-13 Monique Beringer Process for the manufacture of a multi-zone tablet and tablet manufactured by this process
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4753790A (en) * 1986-12-16 1988-06-28 Warner-Lambert Company Sorbitol coated comestible and method of preparation
US4786911A (en) * 1987-11-10 1988-11-22 The Boeing Company Apparatus for circularly polarized radiation from surface wave transmission line

Also Published As

Publication number Publication date
EP0274734B1 (de) 1991-06-19
NZ223160A (en) 1990-09-26
JPS63190822A (ja) 1988-08-08
EP0274734A1 (de) 1988-07-20
IT8719064A0 (it) 1987-01-13
IT1201136B (it) 1989-01-27
AU1017988A (en) 1988-07-14
AU610112B2 (en) 1991-05-16
ES2031491T3 (es) 1992-12-16
DE3770937D1 (de) 1991-07-25
KR880008805A (ko) 1988-09-13
US4865849A (en) 1989-09-12

Similar Documents

Publication Publication Date Title
ATE64528T1 (de) Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.
NO915043D0 (no) Osmoseanordning for kontrollert avgivelse av et nyttig middel
KR900701325A (ko) 속방성 구강 투여용 정제
SE8703034L (sv) Oralt terapeutiskt system med systemisk verkan
DE3878361D1 (de) Umhuellte retardformen.
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
KR880013586A (ko) 고체상태성질을 가진 제거 가능한 기질을 포함하는 투약기
EP0253541A3 (en) Sustained release pharmaceutical compositions in oral dosage form
ATE65023T1 (de) Pharmazeutische mittel.
KR880002502A (ko) 산에 민감한 유익한 약제의 투여용 제형(劑形)
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
ES2035259T3 (es) Compuesto absorbente.
NZ232558A (en) Pulsed release devices for medicaments; capsule which separates and releases contents after a finite time when wetted
IE882898L (en) Solubility modulated drug delivery device

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties